Differences between blacks and whites in plasma protein binding of drugs

被引:24
作者
Johnson, JA
Livingston, TN
机构
[1] Department of Clinical Pharmacy, University of Tennessee - Memphis, Memphis, TN 38163
关键词
plasma protein binding; blacks; whites; differences; alpha(1)-acid glycoprotein;
D O I
10.1007/s002280050235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Disopyramide and salicylic acid were used as model compounds to characterize racial differences in binding of drugs by alpha(1)-acid glycoprotein (AGP) and albumin, respectively. Drug-free plasma was collected from 29 healthy volunteers (15 white, 14 black). Disopyramide and salicylic acid unbound fractions (fu) in plasma were determined by equilibrium dialysis using C-14-disopyramide and C-14-salicylic acid. Results: Disopyramide unbound fractions were significantly higher in blacks than whites (0.131 vs 0.113) as were salicylic acid unbound fractions (0.053 vs 0.048). When unbound fractions were corrected for AGP and albumin concentration, racial differences were no longer present. Conclusion: Many drugs which bind to AGP and/or albumin may exhibit racial differences in unbound fractions. However, these differences are likely explained by differences in protein concentrations rather than differences in the number of binding sites on the protein or racial differences in affinity of the protein for drugs.
引用
收藏
页码:485 / 488
页数:4
相关论文
共 13 条
[1]   THE LOCATION OF DRUG-BINDING SITES IN HUMAN-SERUM ALBUMIN [J].
FEHSKE, KJ ;
MULLER, WE ;
WOLLERT, U .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (07) :687-692
[2]   PROTEIN-BINDING OF DISOPYRAMIDE - DISPLACEMENT BY MONO-N-DEALKYLDISOPYRAMIDE AND VARIATION WITH SOURCE OF ALPHA-1-ACID GLYCOPROTEIN [J].
HAUGHEY, DB ;
STEINBERG, I ;
LEE, MH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (04) :285-288
[3]   EVIDENCE FOR DIFFERENCES IN THE BINDING OF DRUGS TO THE 2 MAIN GENETIC-VARIANTS OF HUMAN ALPHA(1)-ACID GLYCOPROTEIN [J].
HERVE, F ;
GOMAS, E ;
DUCHE, JC ;
TILLEMENT, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (03) :241-249
[5]   RACIAL-DIFFERENCES IN PROPRANOLOL PHARMACOKINETICS [J].
JOHNSON, JA ;
BURLEW, BS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :495-500
[7]  
KRAGHHANSEN U, 1990, MOL PHARMACOL, V37, P238
[8]  
LIMA JJ, 1981, J PHARMACOL EXP THER, V219, P741
[9]   EFFECT OF ALTERED PLASMA-PROTEIN BINDING ON APPARENT VOLUME OF DISTRIBUTION [J].
OIE, S ;
TOZER, TN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (09) :1203-1205
[10]   Racial differences in propranolol enantiomer kinetics following simultaneous iv and oral administration [J].
Sowinski, KM ;
Lima, JJ ;
Burlew, BS ;
Massie, JD ;
Johnson, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) :339-346